内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

OKYO Pharma Ltd

OKYO · Nasdaq · CIK 0001849296 · Healthcare · Biotechnology

内部人信号

69.3 / 100

6 位买方 · 7 条买入交易行 · $136.0K 买入总额

为什么有这个信号？

买方广度较强
买入规模较低
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+35.0 / 35
买入规模+8.8 / 25
角色+13.0 / 20
近期性+2.5 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ 角色得分低 · 买入者中职位最高的是：CHIEF EXECUTIVE OFFICER（CEO、董事长和持股 10% 以上的股东得分最低）
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
CERRONE GABRIELE MDirector,TenPercentOwner
○○●○●
Patil Rajkumar V.Chief Scientific Officer
○●
Dempsey Robert JohnCHIEF EXECUTIVE OFFICER
○●
BRANCACCIO JOHN PDirector
○●
JACOB GARY SCHIEF DEVELOPMENT OFFICER
○●
Mantelli FlavioCHIEF MEDICAL OFFICER
○●
● 买入▼ 卖出○ 其他

—

买方广度与集中度

合资格买方6
买入集中度50%最大买方： CERRONE GABRIELE M · $67.6K
聚集买入 · 15天6 insiders峰值活动： 2026-07-20–2026-07-27

Roles in the peak window: CHIEF DEVELOPMENT OFFICER, CHIEF EXECUTIVE OFFICER, CHIEF MEDICAL OFFICER, Chief Scientific Officer, Director, Director,TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

69.3 / 100

最新留档分数

↓ -0.1 pts相对上一个留档快照
  1. 69.6
  2. 69.4
  3. 69.4
  4. 69.4
  5. 69.3

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

7买入
0卖出
8其他 Form 4 交易行
15SEC 申报 · 365天
买入7 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他8 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-0.7%
3M
-8.4%
6M
-6.0%
12M
-36.6%

波动率与流动性

波动率
80.2%
Beta
—
平均每日成交额
USD 131,605

估值

市值
—
P/E
—

基本面

利润率
—
ROE
—
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
34,643
上期报告
42,141
日均成交量
76,316
回补天数
≤ 1.0

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-07-27Patil Rajkumar V.买入 (P)COMMON STOCK3,363USD 1.49USD 5,011SEC 申报 ↗
2026-07-22Dempsey Robert John买入 (P)COMMON STOCK15,000USD 1.54USD 23,100SEC 申报 ↗
2026-07-21Mantelli Flavio买入 (P)COMMON STOCK20,000USD 1.40USD 28,000SEC 申报 ↗
2026-07-21JACOB GARY S买入 (P)COMMON STOCK3,500USD 1.40USD 4,900SEC 申报 ↗
2026-07-21CERRONE GABRIELE M买入 (P)COMMON STOCK22,500USD 1.45USD 32,625SEC 申报 ↗
2026-07-21BRANCACCIO JOHN P买入 (P)COMMON STOCK5,000USD 1.48USD 7,400SEC 申报 ↗
2026-07-20CERRONE GABRIELE M买入 (P)COMMON STOCK25,000USD 1.40USD 35,000SEC 申报 ↗
2023-09-15BRANCACCIO JOHN P买入 (P)Ordinary Shares16,670USD 1.50USD 25,005SEC 申报 ↗
2022-05-19CERRONE GABRIELE M买入 (P)Ordinary Shares5,800,000USD 0.08USD 464,000SEC 申报 ↗
2022-05-19JACOB GARY S买入 (P)American Depositary Shares12,500USD 4.00USD 50,000SEC 申报 ↗
2022-05-19CERRONE GABRIELE M买入 (P)American Depositary Shares37,500USD 4.00USD 150,000SEC 申报 ↗
2022-05-17CERRONE GABRIELE M买入 (P)Ordinary Shares1,625,000USD 0.06USD 97,500SEC 申报 ↗
2022-05-17CERRONE GABRIELE M买入 (P)American Depositary Shares25,000USD 3.87USD 96,750SEC 申报 ↗

Form 4 申报证据

15 transaction lines in the latest 365-day window; 23 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-07-27Patil Rajkumar V.买入 (P)COMMON STOCK3,363USD 1.49USD 5,011SEC 申报 ↗
2026-07-27Patil Rajkumar V.奖励／授予 (A)COMMON STOCK3,363USD 1.49USD 5,011SEC 申报 ↗
2026-07-22Dempsey Robert John买入 (P)COMMON STOCK15,000USD 1.54USD 23,100SEC 申报 ↗
展开近期 Form 4 证据 (15 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-07-27Patil Rajkumar V.买入 (P)COMMON STOCK3,363USD 1.49USD 5,011SEC 申报 ↗
2026-07-27Patil Rajkumar V.奖励／授予 (A)COMMON STOCK3,363USD 1.49USD 5,011SEC 申报 ↗
2026-07-22Dempsey Robert John买入 (P)COMMON STOCK15,000USD 1.54USD 23,100SEC 申报 ↗
2026-07-22Dempsey Robert John奖励／授予 (A)COMMON STOCK15,000USD 1.54USD 23,100SEC 申报 ↗
2026-07-21Mantelli Flavio买入 (P)COMMON STOCK20,000USD 1.40USD 28,000SEC 申报 ↗
2026-07-21JACOB GARY S买入 (P)COMMON STOCK3,500USD 1.40USD 4,900SEC 申报 ↗
2026-07-21CERRONE GABRIELE M买入 (P)COMMON STOCK22,500USD 1.45USD 32,625SEC 申报 ↗
2026-07-21BRANCACCIO JOHN P买入 (P)COMMON STOCK5,000USD 1.48USD 7,400SEC 申报 ↗
2026-07-21JACOB GARY S奖励／授予 (A)COMMON STOCK3,500USD 1.40USD 4,900SEC 申报 ↗
2026-07-21CERRONE GABRIELE M奖励／授予 (A)COMMON STOCK22,500USD 1.45USD 32,625SEC 申报 ↗
2026-07-21BRANCACCIO JOHN P奖励／授予 (A)COMMON STOCK5,000USD 1.48USD 7,400SEC 申报 ↗
2026-07-21Mantelli Flavio奖励／授予 (A)COMMON STOCK20,000USD 1.40USD 28,000SEC 申报 ↗
2026-07-20CERRONE GABRIELE M买入 (P)COMMON STOCK25,000USD 1.40USD 35,000SEC 申报 ↗
2026-07-20CERRONE GABRIELE M奖励／授予 (A)COMMON STOCK25,000USD 1.40USD 35,000SEC 申报 ↗
2026-06-08CERRONE GABRIELE M奖励／授予 (A)COMMON STOCK300,000USD 1.72USD 516,000SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码OKYO
CIK0001849296
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
交易所Nasdaq

数据覆盖

本地 Form 4 历史23 transaction lines from 2022-05-17 to 2026-07-27
13 P purchase lines · 0 S sale lines · 10 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.